More articles from Review
- Inflammatory myopathies: Narrowing the differential diagnosis
How to differentiate inflammatory myopathy from other causes of muscle weakness.
- It’s a rave new world: Rave culture and illicit drug use in the young
New and potentially dangerous illicit drugs are popular among young people today.
- C-reactive protein: A ‘golden marker’ for inflammation and coronary artery disease
Elevated levels of CRP are associated with increased cardiovascular risk.
- Arrhythmogenic right ventricular cardiomyopathy: A cause of sudden death in young people
A standard history and physical examination will probably not detect this condition, but the history may provide clues.
- Coronary artery disease in women: Different, often undertreated
In coronary artery disease, women are more likely to receive suboptimal and less-aggressive care.
- Is atherosclerosis an infectious disease?
Atherosclerosis is multifactorial, but infection may be a contributing factor. Clinical trials of antibiotics are underway.
- Dofetilide (Tikosyn): A new drug to control atrial fibrillation
The pharmacology of dofetilide, the evidence of its effectiveness, and the appropriate precautions in using it.
- Safe use of sildenafil in patients with coronary artery disease
Despite reports of myocardial infarction and sudden cardiac death in men taking sildenafil (Viagra), most evidence indicates the drug is safe, effective, and well tolerated in most men with coronary artery disease.
- Immunizations in adult immunocompromised patients: Which to use and which to avoid
Immunocompromised patients are particularly susceptible to infectious diseases, but they may not always receive the vaccines they need for protection.
- The challenge of irritable bowel syndrome: Creating an alliance between patient and physician
The key to treating irritable bowel syndrome is to establish a therapeutic physician-patient relationship.